Skip to search formSkip to main contentSkip to account menu

indium-111-octreotide

Known as: (111)In-octreotide, 111In-octreotide, indium 111 octreotide 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

OctreotideRadiopharmaceuticals
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
BACKGROUND Tumor-induced hypophosphatemic osteomalacia is a syndrome characterized by urinary phosphate wasting related to the… 
2003
2003
Effective treatment of bone metastases from a neuroendocrine tumour of the pancreas with high activities of Indium-111-pentetreotide.
OBJECTIVE To evaluate therapy with high doses of (111)Indium pentetreotide in a patient with bone metastases from a carcinoid of… 
1999
1999
Value of peptide receptor imaging using indium-111-octreotide (OCT) and iodine-123 vasoactive intestinal peptide (VIP) in patients with carcinoid tumours: Vienna University experience 1993–1998
1996
1996
Subcutaneous cavernous hemangioma visualized on an indium-111-octreotide scan.
Indium-111-octreotide, a somatostatin analog is the first commercially available receptor-based agent. It shares the binding site… 
1996
1996
In111-octreotide radioguided surgery in operable lung cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)